McGill University has contributed significantly to venous thrombosis research through the COBRRA trial, demonstrating the safety of apixaban over rivaroxaban.
Mcgill: Breaking News: University Suspends In-Person Activities Due to Weather
McGill University has announced the suspension of all in-person activities on March 11, 2026, due to severe weather conditions affecting the Montreal area.